# TB Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tb-biosciences

- Industry: Pharmaceuticals
- Headquarters: Bethlehem, US
- Website: www.tbbiosciences.com
- Total disclosed funding: $1.5M
- Latest round: Series A (Jul 18, 2013)
- Investors on record: 3

## About

TB Biosciences, Inc focuses on providing domain names tailored for the biosciences sector, enhancing digital presence for biotechnology and pharmaceutical businesses.Founded in 2013 and headquartered in Bethlehem, US, TB Biosciences, Inc specializes in offering valuable domain names for the biosciences industry. Notably, the company secured USD 1.5 million in Series A funding led by Originate Ventures in July 2013, with participation from Ben Franklin Technology Partners and NYU Venture Capital. The company has not undergone any notable pivots or changes in its business strategy since inception.TbBiosciences.com primarily offers the domain name for sale via the platform HugeDomains.com. This domain serves as a vital online identity for businesses in biotechnology, pharmaceuticals, and life sciences, aiming to enhance brand visibility and recognition. Its clientele includes startups and established businesses in North America, Europe, and Asia that seek a robust online presence in the biosciences field.Revenue for TB Biosciences, Inc is generated through the sale of the domain name, priced at USD 9,195, with an option for customers to utilize a payment plan of USD 766.25 per month for 12 months. The direct-to-consumer business model facilitates either outright purchases or installment agreements, ensuring a straightforward transaction process without ongoing subscription fees.TB Biosciences, Inc plans to leverage its recent Series A funding to enhance its marketing strategies and expand its reach within the biosciences sector. Although specific new products are not currently in development, the company is focused on exploring additional markets in Europe and Asia by the end of 2024. The recent funding round provides the necessary resources to support these growth initiatives.

## Funding rounds

- Series A, Jul 18, 2013, $1.5M — Ben Franklin Technology Partners, Originate Ventures, NYU Venture Capital

## Investors

- Ben Franklin Technology Partners (https://capitalatlas.ai/funds/ben-franklin-technology-partners) — Series A
- Originate Ventures (https://capitalatlas.ai/funds/originate-ventures) — Series A
- NYU Venture Capital (https://capitalatlas.ai/funds/nyu-venture-capital) — Series A